IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 19 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $524,000 | +0.2% | 52,917 | 0.0% | 0.00% | – |
| Q1 2022 | $523,000 | +1.4% | 52,917 | 0.0% | 0.00% | – |
| Q4 2021 | $516,000 | +11.2% | 52,917 | +13.6% | 0.00% | – |
| Q3 2021 | $464,000 | -0.6% | 46,599 | 0.0% | 0.00% | – |
| Q2 2021 | $467,000 | +135.9% | 46,599 | +133.0% | 0.00% | – |
| Q1 2021 | $198,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |